Acute treatment of critical vascular stenoses with a bioabsorbable magnesium scaffold in infants with CHDs.

The magnesium scaffolds can be used as a bridging solution to treat severe vascular stenosis in different locations. Restenosis can occur after degradation and make further interventions necessary, but neither vessel growth nor further interventions are hindered by stent material. Larger diameters may improve therapeutic options.